insights_auto
Kwa nini 600812 imepungua kwa 4.72%?
Fahamu zaidichevron_right
600812:SHA
North China Pharmaceutical Co Ltd
CN¥ 6.26
arrow_downward
-4.72%(-0.31) Siku 1
16 Okt, 15:00:00 GMT +8 · CNY
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 600812...
Fungua
CN¥ 6.33
Juu
CN¥ 6.90
Chini
CN¥ 6.10
Wastani wa kiasi cha mauzo
61.12M
Kiasi cha mauzo ya hisa
307.76M
Gawio
0.56%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.01
Tarehe ya kutojumuisha gawio
11 Jun 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
87.26
Juu kwa wiki 52
CN¥ 6.90
Chini kwa wiki 52
CN¥ 4.11
EPS
CN¥ 0.07
Hisa za wawekezaji
1.63B
Idadi ya wafanyakazi
elfu 10
Fungua
CN¥ 6.33
Juu
CN¥ 6.90
Chini
CN¥ 6.10
Wastani wa kiasi cha mauzo
61.12M
Kiasi cha mauzo ya hisa
307.76M
Gawio
0.56%
Mgawo wa faida wa kila robo mwaka
CN¥ 0.01
Tarehe ya kutojumuisha gawio
11 Jun 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
87.26
Juu kwa wiki 52
CN¥ 6.90
Chini kwa wiki 52
CN¥ 4.11
EPS
CN¥ 0.07
Hisa za wawekezaji
1.63B
Idadi ya wafanyakazi
elfu 10
Hisa zinazohusiana
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Yahoo! Finance Canada
·
dakika 21 zilizopita
NTHI,TRIN,HERZ,EFOR,FFIN,GO,NXRT,AVBC,BLCO,CULP,VSNT,VIRC,KWY,ENTX,BLIN,GRNT,SSP,GAIA,AFCG,NRGV,APCX,THRY,KLTR,BETR | Stock Prices | Quote Comparison
Seeking Alpha
·
dakika 41 zilizopita
SH: A Tactical Hedge, But Not Yet A Short Call (NYSEARCA:SH)
Foreign Policy Journal
·
dakika 50 zilizopita
Super Micro Computer (NASDAQ: SMCI) Signals Were Visible Before Its Stock 45% Rally
AOL.com
·
saa 7 zilizopita
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Wasifu
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Kuhusu North China Pharmaceutical Co Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 9.97
Lilianzishwa20 Des 1992
Makao makuu-
Sekta-
Tovuti-